Gambacorta, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 17.499
EU - Europa 10.839
AS - Asia 10.421
SA - Sud America 1.988
Continente sconosciuto - Info sul continente non disponibili 542
AF - Africa 352
OC - Oceania 54
Totale 41.695
Nazione #
US - Stati Uniti d'America 17.026
SG - Singapore 4.652
DE - Germania 3.187
CN - Cina 2.057
IT - Italia 1.713
SE - Svezia 1.658
BR - Brasile 1.606
VN - Vietnam 1.132
FR - Francia 881
NL - Olanda 780
IN - India 642
GB - Regno Unito 522
IE - Irlanda 458
UA - Ucraina 375
FI - Finlandia 321
ID - Indonesia 309
JP - Giappone 281
HK - Hong Kong 279
BD - Bangladesh 267
CA - Canada 224
PL - Polonia 205
RU - Federazione Russa 199
AR - Argentina 143
TR - Turchia 141
MX - Messico 136
IQ - Iraq 130
AT - Austria 97
BE - Belgio 97
PK - Pakistan 85
ZA - Sudafrica 84
ES - Italia 70
KR - Corea 70
CI - Costa d'Avorio 66
CZ - Repubblica Ceca 60
EC - Ecuador 49
CO - Colombia 45
PH - Filippine 43
MA - Marocco 41
AU - Australia 40
SA - Arabia Saudita 40
VE - Venezuela 38
IR - Iran 37
LT - Lituania 36
CL - Cile 31
KE - Kenya 30
CH - Svizzera 29
UZ - Uzbekistan 29
PE - Perù 26
EG - Egitto 25
JO - Giordania 25
IL - Israele 24
JM - Giamaica 24
AE - Emirati Arabi Uniti 23
TN - Tunisia 22
RO - Romania 21
DZ - Algeria 20
PY - Paraguay 20
UY - Uruguay 20
CR - Costa Rica 19
GR - Grecia 18
MY - Malesia 18
AL - Albania 17
AZ - Azerbaigian 15
PA - Panama 15
KZ - Kazakistan 14
NZ - Nuova Zelanda 14
ET - Etiopia 13
BG - Bulgaria 12
NP - Nepal 11
SN - Senegal 11
TT - Trinidad e Tobago 11
BH - Bahrain 10
NG - Nigeria 10
RS - Serbia 10
TH - Thailandia 10
TW - Taiwan 10
AM - Armenia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
NI - Nicaragua 9
PS - Palestinian Territory 9
PT - Portogallo 9
BO - Bolivia 8
NO - Norvegia 8
OM - Oman 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
EU - Europa 7
GE - Georgia 7
GT - Guatemala 7
HU - Ungheria 7
KG - Kirghizistan 6
LK - Sri Lanka 6
AO - Angola 5
BB - Barbados 5
BY - Bielorussia 5
LV - Lettonia 5
MD - Moldavia 5
MN - Mongolia 5
MT - Malta 5
Totale 41.096
Città #
Singapore 2.629
Chandler 1.765
San Jose 1.525
Ashburn 1.458
Amsterdam 708
Los Angeles 540
New York 524
Beijing 468
Dublin 455
Ho Chi Minh City 401
Rome 359
Frankfurt am Main 307
Milan 305
The Dalles 291
Lauterbourg 278
Ann Arbor 274
Hanoi 262
Jakarta 260
Tokyo 259
Jacksonville 255
Hyderabad 247
Hong Kong 244
San Mateo 243
Munich 237
Hefei 218
Wilmington 172
St Louis 166
São Paulo 158
Dallas 153
Boston 149
Princeton 144
Warsaw 144
Atlanta 141
Helsinki 138
Nanjing 135
Nürnberg 131
Houston 125
Chicago 123
Moscow 119
Marseille 118
Bremen 112
Cattolica 112
Santa Clara 110
Dearborn 109
Woodbridge 103
Buffalo 96
Fairfield 96
Council Bluffs 94
Brussels 90
London 82
Redwood City 81
Brooklyn 77
Seattle 73
Orem 72
Da Nang 71
Phoenix 68
Abidjan 66
Lawrence 66
Boardman 65
Seoul 64
Turku 63
Nuremberg 62
Denver 59
Toronto 59
Kent 58
Washington 54
Izmir 53
Paris 50
Montreal 49
Nanchang 49
Vienna 49
Chennai 47
Düsseldorf 47
Leawood 47
Haiphong 46
Lappeenranta 45
Stockholm 45
Johannesburg 44
Memphis 44
Rio de Janeiro 44
Baghdad 42
Mexico City 41
North Bergen 41
Zhengzhou 41
Poplar 40
San Francisco 40
Detroit 39
Shenyang 38
Augusta 36
Brno 35
Shanghai 35
Columbus 33
Manchester 33
Falkenstein 32
Guangzhou 32
Falls Church 30
Norwalk 30
Pune 30
Tianjin 30
Belo Horizonte 29
Totale 20.056
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 1.003
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 566
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 525
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 382
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 338
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 306
Art and digital technologies to support resilience during the oncological journey: The Art4ART project 302
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 299
An exploratory assessment of early and delta PET radiomic features for outcome prediction in locally advanced cervical cancer 294
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 287
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 275
Auto-segmentation of pelvic organs at risk on 0.35T MRI using 2D and 3D Generative Adversarial Network models 269
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 238
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 233
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art 229
Quality control strategies for head and neck brachytherapy (interventional radiotherapy) 228
Gender role in radiotherapy: psychosocial differences between males and females during cancer care: Single-centre report on adult and paediatric oncological patients 228
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 228
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 227
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 226
Early post-operative NI-RADS predicts recurrence and survival in high-risk oral cavity squamous cell carcinoma undergoing adjuvant radiotherapy 225
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 225
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 225
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 220
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 214
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 213
Patients’ perspective in anal cancer 212
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 204
Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer 203
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 202
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 201
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up') 200
Lung recruitment strategies and surfactant in neonatal intensive care unit 200
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 200
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 199
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 196
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 196
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 196
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 194
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 194
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 193
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 193
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 185
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 184
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 182
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer 181
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 181
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 179
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 178
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 178
In vivo dosimetry using an electronic portal imaging device for pediatric myeloablative Total body irradiation with volumetric modulated arc therapy 177
THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis 176
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 176
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 175
Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review 175
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 173
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 172
TIMER (gemelli arT Interstitial Multi-imaging pERineal applicator): Dosimetric analysis of homemade device for interventional radiotherapy (brachytherapy) 171
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 171
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 170
Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms 170
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 169
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 165
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 165
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 165
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 165
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 163
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 162
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 161
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 160
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation 159
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 159
Assessing Quality of Life with the Novel QLQ-CAX24 Questionnaire and Body Composition Parameters in Rectal Cancer Patients: A Single-Center Prospective Study 158
Modern Techniques in Re-Irradiation for Locally Recurrent Rectal Cancer: A Systematic Review 156
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 155
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 154
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 154
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 153
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 153
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer 152
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 152
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 150
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 149
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 148
The impact of radiomics in diagnosis and staging of pancreatic cancer 148
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 147
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 147
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 146
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 145
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology 145
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 144
Magnetic resonance–guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system 144
Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives 143
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 143
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 141
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 141
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 141
Totale 20.634
Categoria #
all - tutte 162.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.821 0 77 35 163 84 68 32 266 132 142 440 382
2022/20234.910 641 644 369 762 272 584 257 388 575 153 189 76
2023/20242.637 106 684 127 185 129 460 164 94 31 95 274 288
2024/20255.795 112 149 411 219 582 230 233 228 764 696 1.230 941
2025/202616.603 2.028 447 871 1.699 2.522 2.298 2.640 888 972 1.160 633 445
2026/20274.658 854 3.804 0 0 0 0 0 0 0 0 0 0
Totale 41.695